Neurological Examination

MENTAL STATUS

Level of Consciousness: Note whether the patient is:

  • Alert/responsive
  • Not alert but arouses to verbal stimulation
  • Not alert but responds to painful stimulation
  • Unresponsive

Orientation: Assess the patient’s ability to provide:

  • Name
  • Current location
  • Current date
  • Current situation (e.g., ask the patient what happened to him/her)

Language: Note the fluency and appropriateness of the patient’s response to questions. Note patient’s ability to follow commands when assessing other functions (e.g., smiling, grip strength, wiggling toes). Ask the patient to name a simple object (e.g., thumb, glove, watch).

Speech: Observe for evidence of slurred speech.

CRANIAL NERVES

All patients:

  • Assess the pupillary response to light.
  • Assess position of the eyes and note any movements (e.g., midline, gaze deviated left or right, nystagmus, eyes move together versus uncoupled movements).
  • Noncomatose patient:
  • Test sensation to light touch on both sides of the face.
  • Ask patient to smile and raise eyebrows, and observe for symmetry.
  • Ask the patient to say “Ahhh” and directly observe for symmetric palatal elevation.
  • Comatose patient:
  • Check corneal reflexes; stimulation should trigger eyelid closure.
  • Observe for facial grimacing with painful stimuli.
  • Note symmetry and strength.
  • Directly stimulate the back of the throat and look for a gag, tearing, and/or cough.

MOTOR

Tone: Note whether resting tone is increased (i.e. spastic or rigid), normal, or decreased (flaccid).

Strength: Observe for spontaneous movement of extremities and note any asymmetry of movement (i.e. patient moves left side more than right side). Lift arms and legs, and note whether the limbs fall immediately, drift, or can be maintained against gravity. Push and pull against the upper and lower extremities and note any resistance given. Note any differences in resistance provided between the left and right sides.

(NOTE: it is often difficult to perform formal strength testing in TBI patients. Unless the patient is awake and cooperative, reliable strength testing is difficult.)

Involuntary movements: Note any involuntary movements (e.g., twitching, tremor, myoclonus) involving the face, arms, legs, or trunk.

SENSORY

If patient is not responsive to voice, test central pain and peripheral pain.

Central pain: Apply a sternal rub or supraorbital pressure, and note the response (e.g., extensor posturing, flexor posturing, localization).

Peripheral pain: Apply nail bed pressure or take muscle between the fingers, compress, and rotate the wrist (do not pinch the skin). Muscle in the axillary region and inner thigh is recommended. Apply similar stimulus to all four limbs and note the response (e.g., extensor posturing, flexor posturing, withdrawal, localization).

NOTE: In an awake and cooperative patient, testing light touch is recommended. It is unnecessary to apply painful stimuli to an awake and cooperative patient.

GAIT

If the patient is able to walk, observe his/her casual gait and note any instability, drift, sway, and so forth.

Ultrasonic Assessment of Optic Nerve Sheath Diameter

If a patient is unconscious (i.e. does not follow commands or open eyes spontaneously), they may have elevated ICP. There is no reliable test for elevated ICP available outside of a hospital; however, optic nerve sheath diameter (ONSD) measurement is a rapid, safe, and easy-to-perform ultrasonographic assessment that may help identify elevated ICP when more definitive monitoring devices are not available.

  • The optic nerve sheath directly communicates with the intracranial subarachnoid space. Increased ICP, therefore, displaces cerebrospinal fluid along this pathway. Normal ONSD is 4.1–5.9mm.30
  • A 10–5-MHz linear ultrasound probe can be used to obtain ONSDs. ONSD is measured from one side of the optic nerve sheath to the other at a distance of 3mm behind the eye immediately below the sclera.31
  • In general, ONSDs >5.2mm should raise concern for clinically significant elevations in ICP in unconscious TBI patients.5,32 The ONSD can vary significantly in normal individuals, so one single measurement may not be helpful; however, repeated measurements that detect gradual increases in ONSD over time may be more useful than a single measurement.
  • ONSD changes rapidly when the ICP changes, so it can be measured frequently.33 If ONSD is used, it is best to check hourly along with the neurologic examination.

Technique

  1. Check to make sure there is no eye injury. A penetrating injury to the eyeball is an absolute contraindication to ultrasound because it puts pressure on the eye.
  2. Ensure the head and neck are in a midline position. Gentle sedation and/or analgesia may be necessary to obtain accurate measurements.
  3. Ensure the eyelids are closed.
  4. If available, place a thin, transparent film (e.g., Tegaderm; 3M, http://www.3m.com) over the closed eyelids.
  5. Apply a small amount of ultrasound gel to closed eyelid.
  6. Place the 10(–5) MHz linear probe over the eyelid. The probe should be applied in a horizontal orientation (Figure 1) with as little pressure as possible applied to the globe.
  7. Manipulate the probe until the nerve and nerve sheath are visible at the bottom of screen. An example of a proper ultrasonagraphic image of the optic nerve sheath can be seen in Figure 2.
  8. Once the optic nerve sheath is visualized, freeze the image on the screen.
  9. Using the device’s measuring tool, measure 3mm back from the optic disc and then obtain a second measurement perpendicular to the first. The second measurement should cover the horizontal width of the optic nerve sheath (Figure 2). An abnormal ONSD is shown in Figure 3.
  10. Repeat the previous sequence in the opposite eye. Annotate both ONSDs on the PFC Casualty Card.
  11. ONSDs should be obtained, when possible, at regular intervals to help assess changes in ICP, particularly when the neurologic examination is poor and/or unreliable (i.e. with sedation). Serial measurements with progressive diameter enlargement and/or asymmetry in ONSDs should be considered indicative of worsening intracranial hypertension.

CAUTION: ONSD measurements are contraindicated in eye injuries. NEVER apply pressure to an injured eye.

Spontaneous Venous Pulsations

  • Spontaneous venous pulsations (SVPs) are subtle, rhythmic variations in retinal vein caliber on the optic disc and have an association with ICP.
  • It is difficult to see SVPs without advanced equipment; however, if a handheld ophthalmoscope is available, it is worth an attempt to visualize the retinal veins.
  • Don’t worry if you cannot see SVPs; this may actually be normal. However, if you do see them, it is very reassuring that ICP is normal.10
  • If SVPs are initially present and can no longer be seen on subsequent examinations, the provider should be concerned for increasing ICP.

Technique

  1. Gently lift the eyelid until the pupil is in view.
  2. Using a handheld ophthalmoscope, the provider should maneuver himself or herself to a position where the optic disc can be visualized.
  3. Identify the retinal veins as they emerge from the optic disc. Retinal veins are typically slightly larger and darker than retinal arteries. Figure at right demonstrates the typical appearance of the retina.
  4. Observe the retinal veins for pulsations. Note the presence or absence of spontaneous venous pulsations
  5. Repeat the step 1–4 sequence in the contralateral eye.

Glasgow Coma Scale

TBI severity classification using the GCS score:

  • Mild: 13–15
  • Moderate: 9–12
  • Severe: 3–8

Richmond Agitation Sedation Scale (RASS)

Signs and Symptoms of Elevated Intracranial Pressure   

  • GCS<8 and suspected TBI
  • Rapid decline in mental status
  • Fixed dilated pupils(s)
  • Cushing’s triad hemodynamics (hypertension, bradycardia, altered respirations)
  • Motor posturing (unilateral or bilateral)
  • Penetrating brain injury and GCS <15
  • Open skull fracture

 

Hypertonic Saline (HTS) Protocol (goal Na 140-165 meq/L)

  • 3% HTS: 250-500 cc bolus, then 50 ml/hr infusion, rebolus as needed for clinical signs
  • 5% HTS: decrease above doses by 50%
  • 4%: dilute to 3% and use as above. If unable to dilute, can be given as 30 ml bolus and re-dose as needed.
  • Central venous line (CVL) preferred for 3% (can be given initially via peripheral IV/IO)
  • CVL REQUIRED for 7.5% or higher concentration

 

Military Acute Concussion Evaluation 2 (MACE 2) Form, 2021

Open the attachment on the side menu or open the below link to print or fill out electronically.

https://www.health.mil/Reference-Center/Publications/2020/07/30/Military-Acute-Concussion-Evaluation-MACE-2

 

MHS Progressive Return to Activity Following Acute Concussion/Mild TBI

Open the attachment on the side menu or open the below link to print or fill out electronically.

https://jts.amedd.army.mil/assets/docs/cpgs/Progressive_Return_to_Activity_Following_Acute_Concussion_mTBI_Clinical_Recommendation_2021.pdf